000			03409nam a2200445 i 4500
999			_c361341 _d361341
001			361341
003			ES-MaUEC
005			20230102121345.0
006			a||||fo|||| 00| 0
007			cr nn nnnaamaa
008			211030s2021 sz | o |||| 0|eng d
020			_a9783030795115
024	7		_a10.1007/978-3-030-79511-5 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRM300 _b2021 EB
245	0	4	_aThe Carbonic Anhydrases : _bCurrent and Emerging Therapeutic Targets _cedited by W. Richard Chegwidden, Nicholas D. Carter
250			_aFirst edition 2021
264		1	_aCham _bSpringer International Publishing _c2021
300			_a1 recurso en línea (XII, 288 páginas) _b38 ilustraciones, 22 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_aArchivo de texto _bPDF
490	0		_aProgress in Drug Research _x2297-4555 _v75
490	0		_aBiomedical and Life Sciences (SpringerNature-11642)
490	0		_aBiomedical and Life Sciences (R0) (SpringerNature-43708)
505	0		_aDedication -- Preface.-The carbonic anhydrases in health and disease -- Carbonic anhydrase isozymes as diagnostic biomarkers and therapeutic targets -- Targeting carbonic anhydrases in vascular and pulmonary disease -- Carbonic anhydrase inhibitors in ophthalmology: glaucoma and macular oedema -- Targeting carbonic anhydrase isozymes in the treatment of neurological disorders -- Potential of carbonic anhydrase inhibitors in the treatment of oxidative stress and diabetes -- An overview of carbonic anhydrase-related neoplasms -- The carbonic anhydrase IX interactome and the regulation of cancer progression -- Carbonic anhydrase IX: current and emerging therapies -- Carbonic anhydrase inhibitors: designing isozyme-specific inhibitors as therapeutic agents -- Carbonic anhydrase inhibitors: identifying therapeutic cancer agents through virtual screening -- Targeting carbonic anhydrase IX in tumour imaging and theranostic cancer therapy.
520	3		_aThis volume assembles and integrates the wealth of diverse information that is now accumulating in this burgeoning field. The existing and potential therapeutic applications of targeting CA cover a remarkably wide-range of diseases and disorders and have generated increasing and extensive interest in recent years. Its inter-disciplinary approach embraces both the most up-to-date therapeutic application of CA-targeting and the latest research data that will provide a platform for the development of novel applications. The interested audience comprises scientists and clinicians from many relevant disciplines within science and medicine.
988			_aSpringer_BiomedLife_2021
650		7	_2embne _aFarmacología _9137893
650		7	_2embne _9149316 _aBioquímica clínica
700	1		_aChegwidden, W. R. _q(W. Richard), _d1947- _eeditor literario _9680790
700	1		_aCarter, N. D. _eeditor literario _9680791 _q(Nicholas D.)
776	0	8	_iPrinted edition: _z9783030795108
776	0	8	_iPrinted edition: _z9783030795122
776	0	8	_iPrinted edition: _z9783030795139
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-79511-5 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b01/2022 _dz _eb _zSI